Hansel M. Greiner
Papers
1
Total Citations
18
H-Index
1
About
Hansel M. Greiner is a leading pediatric epileptologist whose research focuses on advancing surgical and neuromodulation therapies for children with drug-resistant epilepsy. His major contributions center on evaluating the safety and efficacy of responsive neurostimulation (RNS) device therapy in pediatric populations—a group historically underrepresented in clinical trials for such interventions. In his highly cited 2022 study, Greiner demonstrated that RNS can significantly reduce seizure frequency in children with complex, medically refractory epilepsy, offering a crucial alternative when traditional medications and resective surgery fail. This work has garnered 18 citations and has helped shift clinical practice toward earlier consideration of neuromodulation in pediatric epilepsy care. Greiner’s research is notable for its direct impact on improving quality of life in young patients with severe epilepsy, and he continues to advocate for expanded surgical options in this vulnerable population. His contributions are shaping the standard of care for pediatric epilepsy, bridging the gap between adult neuromodulation evidence and the unique needs of children.
Research Focus
Key Achievements
Top Papers
- 1